Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Deep brain stimulation (DBS) is an effective therapy for various neurologic and neuropsychiatric disorders, involving chronic implantation of electrodes into target brain regions for electrical stimulation delivery. Despite its safety and efficacy, DBS remains an underutilized therapy. Advances in the field of DBS, including in technology, mechanistic understanding, and applications have the potential to expand access and use of DBS, while also improving clinical outcomes. Developments in DBS technology, such as MRI compatibility and bidirectional DBS systems capable of sensing neural activity while providing therapeutic stimulation, have enabled advances in our understanding of DBS mechanisms and its application. In this review, we summarize recent work exploring DBS modulation of target networks. We also cover current work focusing on improved programming and the development of novel stimulation paradigms that go beyond current standards of DBS, many of which are enabled by sensing-enabled DBS systems and have the potential to expand access to DBS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634582PMC
http://dx.doi.org/10.1523/JNEUROSCI.1427-23.2023DOI Listing

Publication Analysis

Top Keywords

dbs
11
deep brain
8
brain stimulation
8
potential expand
8
expand access
8
access dbs
8
dbs systems
8
stimulation
5
advances deep
4
stimulation mechanisms
4

Similar Publications

Background: Children in low- and middle-income countries face obstacles to optimal language and cognitive development due to a variety of factors related to adverse socioeconomic conditions. One of these factors is compromised caregiver-child interactions and associated pressures on parenting. Early development interventions, such as dialogic book-sharing (DBS), address this variable, with evidence from both high-income countries and urban areas of low- and middle-income countries showing that such interventions enhance caregiver-child interaction and the associated benefits for child cognitive and socioemotional development.

View Article and Find Full Text PDF

Objective: To estimate the prevalence of various hemoglobinopathies among newborns, women in antenatal clinic and children presenting with signs and symptoms suggestive of sickle cell disease (SCD).

Methods: A hospital-based prospective study was conducted at a Centre of Excellence for SCD (COESCD). Dried blood spot (DBS) samples were collected for newborn screening using heel-prick and venous samples were used in the post-neonatal age group.

View Article and Find Full Text PDF

Background: The factors contributing to a poor response to subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD) are not yet fully understood. Accordingly, predicting the outcome might be challenging particularly in those who display an optimal response to the Levodopa challenge test.

Objective: To determine which factors may contribute to poor outcome of STN-DBS in PD.

View Article and Find Full Text PDF

Peri-lead edema in deep brain stimulation: common complication or rare challenge?

Front Surg

August 2025

Department of Neurology, University Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czechia.

Introduction: Peri-lead edema (PLE) is a commonly observed but often asymptomatic complication of deep brain stimulation (DBS). While usually transient and benign, severe cases of PLE can result in neurological symptoms, impacting patient outcomes. This case series explores the clinical course, management, and outcomes of symptomatic PLE in a series of five patients undergoing DBS.

View Article and Find Full Text PDF

Deep brain stimulation (DBS) and the use of directional subsegmental stimulation have significantly advanced symptom management in patients with Parkinson's disease (PD) and essential tremor (ET). This study examines the use of directional programming in a tertiary care center. We retrospectively reviewed medical records of 12 PD patients (all with bilateral subthalamic nucleus (STN) implants) and 13 ET patients (12 with bilateral and 1 with unilateral ventral intermediate nucleus (VIM) implants) who received directional leads.

View Article and Find Full Text PDF